This is 🤯 All publicly available. Looks like an amazing new histology-based human probabilistic atlas and parcellation tool. #neuroskyence #mri #brainmapping A probabilistic histological atlas of the human brain for MRI segmentation | Nature share.google/5AD0iW7pxgb4...

Meet @ucl.ac.uk's neuroscience experts at London/UK @buildsbio.bsky.social Inaugural Symposium on 20 Nov during London Life Science Week! Gain expert insights from our scientists on neurodegenerative diseases and network with key players across life sciences. Details: bit.ly/3WBzPm4

New research shows grey matter networks in early #multiplesclerosis have a biphasic response to the first demyelinating attack 👉 buff.ly/9iv1vKJ @SaraCollorone

Best of luck to all the nominees at the @womeninneurouk.bsky.social Awards 2025 this evening!🥇 We're a proud sponsor of the Leading Researcher Award: Sex/Gender in Neuroscience 💫 Read more 👉 www.womeninneuroscienceuk.org/winuk-awards...

📻 Tune in to Times Radio to hear Professor Nick Fox (@uclqsion.bsky.social) discussing early onset dementia and what he hopes the new Hilary and Galen Weston Rare Dementia Support Centre at UCL will achieve. Listen from 57 mins:

A new AI-assisted brain atlas that can help visualise the human brain in unprecedented detail has been developed by @uclqsion.bsky.social researchers.

A new AI-assisted brain atlas that can visualise the human brain in unprecedented detail has been developed by a team led by Dr Juan Eugenio Iglesias @uclengineering.bsky.social & Dr Zane Jaunmuktane @uclbrainscience.bsky.social, in a major advance in neuroimaging www.ucl.ac.uk/news/2025/no...

🔬 These images show forebrain organoids that are grown at the UCL Wray Lab to study dementia. This research focuses on a genetic form of frontotemporal dementia, and the colours confirm that the organoids have developing neurons (neural progenitors). 📸: Sophie Goldsmith, @uclqsion.bsky.social

Congrats to Peter Finnigan, a Highly Specialist Neuromuscular Physio from NHNN’s Highly Specialist McArdle & Related Disorders Service, on his Small Acorns grant from The National Brain Appeal of £5,691.60 to establish normative strength profiles and quantify sarcopenia risk in McArdle disease👏

Excellent recent series from @thelancet.com on Alzheimer's disease bringing together international experts including Prof Nick Fox (UK DRI at UCL) to distill a century of research into actionable insights 🧠 Read the full series 👉 www.thelancet.com/series-do/al...

Next year, a pioneering service at UCL will support thousands of people diagnosed with rare dementia, combining science with emotional support. (£wall) @uclqsion.bsky.social

Congratulations to all the finalists in the #WiNUKAwards 2025! 👏 Fantastic to see so many familiar faces across the categories - best of luck to everyone who is nominated 🤞 @soyonhonglab.bsky.social @sorayam.bsky.social @clairedurrant1.bsky.social

#BrainMeeting 🧠 Alert! 🎺 This Friday, November 7th, the Brain Meeting speaker will be Simon Van Gaal giving a talk entitled "Linking global state fluctuations and recurrent processing to conscious perception in humans" In person or online. For more information: www.fil.ion.ucl.ac.uk/event

New #neurojob #psychiatryjob #jobalert. www.northlondonmentalhealth.nhs.uk/current-vaca.... Focus is on clinical trials for mood disorders, with close links to @uclpsychiatry.bsky.social @uclqsion.bsky.social and @mpc-comppsych.bsky.social

“I’ve seen people as early as their 20s with dementia, and it doesn’t have to affect memory": Prof Nick Fox @uclqsion.bsky.social discusses the establishment of The Hilary and Galen Weston Rare Dementia Support Centre at UCL, which will offer critical services for those impacted by rare dementias

A wonderful article on the new rare dementia support Centre at UCL. This will make such a huge difference to those with young onset and atypical forms of dementia. ‘I see people with dementia in their 20s’: first centre for young patients www.thetimes.com/article/7bc1...

🧟This Halloween, explore how eerie experiments and 19th-century neuroscience shaped the darkest corners of gothic literature. Join @selinawray.bsky.social, @caswell.bsky.social & @drjlange.bsky.social for a spooktacular Brain Stories. 🎃 Listen: share.transistor.fm/s/51e18001 @uclqsion.bsky.social

🚨Join our next @DEMONNetworkUK #Genetics and #Omics joint with #Biomarkers meeting on THURSDAY 6th November at 2.30 PM (UK Time). Delighted to have Asger Wretlind as invited speaker – “Unsaturated #Lipid Deficits: A #Female Specific #Alzheimer's Signature” Join the network or DM for more info!

A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery in a study led by @uclqsion.bsky.social and UCLH clinical researchers.

🗣️ Professor Paola Giunti (@uclqsion.bsky.social) said: "The earlier you treat the patient, the better the outcome. We don't want our patients to wait for years before having the drug."

Just a few weeks left to apply for our clinical PhD programme. We're looking for clinicians who are passionate about research to join the 3-year fully funded programme. Learn more and see what positions are available ⬇️ www.crick.ac.uk/careers-and-...

In the mood for something sciency and spooky? How about the Halloween special of @uclbrainstories.bsky.social - where me and @caswell.bsky.social talk to @drjlange.bsky.social on some of the gothic stories in neuroscience! 👻 🧠 🎃 💀🧟‍♂️ spotify.link/2lHT9pLQRXb

New from #UCL: Faces of UCL, hosted by President & Provost Dr Michael Spence. Ordinary people, extraordinary stories - from curating Egyptian artefacts to decoding dementia. Listen now https://www.ucl.ac.uk/about/ucls-bicentenary/faces-ucl-podcast #UCLPodcasts

🎶 Can music help heal the brain after injury? This #WorldStrokeDay we speak to Dr Sara Ajina (@uclqsion.bsky.social) about her pioneering trial at UCLH to find out the impact of music therapy. www.ucl.ac.uk/brain-scienc...

To mark #WorldStrokeDay we caught up with Prof David Werring, (@uclqsion.bsky.social) to ask what the most effective strategies are for stroke prevention, how technology is being used to improve diagnosis and treatment, and much more. www.ucl.ac.uk/brain-scienc...

First Neuralink patient at University College London Hospital. Great news for these patients. The initial technology was largely developed in universities, with public funds. I hope there will be competition in this space (but I worry that the market is small). www.uclh.nhs.uk/news/first-u...

A groundbreaking multiple sclerosis trial, that could offer hope to millions, has begun using Autolus Therapeutics CAR T-cell therapy platform. Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust. 1/

👟 Meet Joe Gregory — England walking footballer and Parkinson’s research champion. He’s taken part in a whopping 12 research projects at @uclqsion.bsky.social and other universities to help find better treatments. 📖 Read more: www.ucl.ac.uk/brain-scienc...

A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease. @uclqsion.bsky.social www.ucl.ac.uk/news/2025/oc...

NMRR were in Antwerp this week, presenting our work at the European CMT Federation scientific meeting. It was great to have the opportunity to share the Better Balance-NMD program, & highlight the importance & directions of rehab research for Charcot-Marie-Tooth disease. 1/3

To mark International Brain Tumour Awareness Week, we revisit our interview with Dr James Ruffle (@uclqsion.bsky.social) in which we find out how AI is transforming brain cancer research and care. #IBTAWeek www.ucl.ac.uk/brain-scienc...

New study on the thalamic involvement in genetic #FTD, using an automated tool that combines structural and diffusion 🧠 MRI doi.org/10.1093/brai...

Parkinson’s is now the fastest growing neurological condition in the world. In this podcast, Dr Sonia Gandhi (@uclqsion.bsky.social) shares more about her work to reverse that trend. 🎧 Listen now:

We are excited to welcome Huw Morris, MD, PhD, and Ed Jabbari, MBBS, PhD, from University College London as the October LRRK2 Central #webinar speakers. 👇 Reserve your spot using the link below. 📅 October 30, 2025 ⏰ 1:00 PM ET RSVP: bit.ly/47c5Ve9

A UK first: a patient with multiple sclerosis has received CAR T-cell therapy in a trial testing whether this personalised treatment could slow or even halt disease progression. “Our ultimate goal is to achieve long periods of remission with a single, one-time CAR T treatment.” - Dr Claire Roddie

Congratulations to Filipe Nascimento on successfully being awarded a Wellcome Trust Career Development Award (CDA) - ‘Spinal microcircuit resilience in Amyotrophic Lateral Sclerosis (ALS): mechanisms, translational insights and therapeutic windows’, starting in April 2026.

It was a great pleasure to present our work on #epigenetics, #oligodendrocytes and #neurodegeneration at the "White Matter in Focus symposium" in Cambridge today. Lots of inspiring talks and networking. Thank you to the organisers and sponsors for this opportunity 😊!

🌟Job opportunity 🌟 We are now recruiting a Research Fellow to work on a research project involving the role of the gut-brain axis in Parkinson’s disease. 🗓️ Deadline: Thursday 30 October Find out more + please share with your networks 👉 tinyurl.com/ypjypz66

✍️ Apply now! Clinical Fellowship in imaging for evaluation of mitochondrial disease severity, progression, and treatment response, in our excellent & supportive team at UCL Queen Square / UCLH NHS Highly Specialised Service for Rare Mitochondrial Disorders shorturl.at/jaSke

New episode of @uclbrainstories.bsky.social is out! Me & @smfleming.bsky.social chat to our cohost @caswell.bsky.social & Lucy Unwin about their new book “Inside your Brain”. Have a listen & buy the book for any budding young neuroscientists in your life! podcasts.apple.com/gb/podcast/b...

🎖️ Huge congratulations to Professor Bart De Strooper (@ukdri.ac.uk, @uclqsion.bsky.social) who has been awarded an honorary CBE for his services to dementia research in the UK and internationally. www.ucl.ac.uk/news/2025/oc...

Congratulations to Professor Bart De Strooper @uclqsion.bsky.social on receiving an honorary CBE for his internationally-renowned research on Alzheimer's disease and for his leadership as founding director of the @ukdri.ac.uk, which he led from its hub at UCL.

‪ ✍️ Apply now! Clinical Fellowship in imaging for evaluation of mitochondrial disease severity, progression, and treatment response, in our excellent & supportive team at UCL Queen Square / UCLH NHS Highly Specialised Service for Rare Mitochondrial Disorders shorturl.at/jaSke

Huge congratulations to UK DRI Founding Director Prof Bart De Strooper who has been awarded an Honorary CBE for his contributions to dementia research! 👏 Read more👉 buff.ly/xhKD5Aj

We're delighted to announce that Professor Simon Shorvon has received the 2025 Lifetime Achievement Award for Services in Epilepsy awarded jointly by the International League Against Epilepsy and International Bureau for Epilepsy. @ilae-epilepsy.bsky.social www.ucl.ac.uk/brain-scienc...

Chairing the #WFN Aphasia, Dementia & Cognitive Disorders group it´s proving to be one of the most rewarding privileges of my professional life. Proud to share our group’s highlights from the #WorldCongressofNeurology in Seoul: tinyurl.com/5apzvnb4 @uclbrainscience.bsky.social

#BrainMeeting 🧠 Alert! 🎺 This Friday, October 24th, the Brain Meeting speaker will be Terence Sanger, MD, PhD. This talk will be online only. 12 Queen Square Seminar room (4th Floor) will be available if you need a space to watch the stream. For more information: www.fil.ion.ucl.ac.uk/event

UCL Department of Neuromuscular Diseases seeks a Database Manager / Trials Coordinator to support TRANSFORM-CMT led by Professor Mary Reilly. Closing date: 29th October www.dementiaresearcher.nihr.ac.uk/job/database...

🎧 Have a listen to @uclqsion.bsky.social researchers discussing the amazing breakthrough for Huntington's disease treatment that has been making headlines around the world and find out what hope this may offer to families.

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at @uclqsion.bsky.social @uclh.bsky.social and @newcastleuni.bsky.social, accelerating the search for effective treatments in a £26 million project #ejsactpd